Tuesday, December 5, 2023


Ministerial screening: NAFDAC is not functioning — fake drugs are killing people, says Tunji Alausa

Ministerial screening: NAFDAC is not functioning — fake drugs are killing people, says Tunji Alausa
August 04
18:18 2023

Tunji Alausa, a nephrologist, says the National Agency for Food and Drug Administration and Control (NAFDAC) has failed in its mandate to regulate the prevalence of fake drugs in the country.

Speaking on Friday when he appeared before the senate for screening as a ministerial nominee, Alausa said the regulatory agency needs urgent reform.

Alausa, a nominee from Lagos, said the country’s healthcare system is “really suboptimal”.

He said Nigeria needs to build a quality regulatory body to “take care” and tackle the fake drugs in pharmaceutical stores across the country.


“With regards to NAFDAC, it is sad to say that beyond these fake pharmaceutical companies, these drugs are killing our people,” he said.

“A lot of people are developing kidney failure because of counterfeit drugs. This is even causing more morbidity in our society.

“It is very unfortunate to say today that NAFDAC is not functioning the way it should be. It’s not functioning.


“If given the opportunity, that will be one of the first agencies that I will totally reform. It’s not functioning. NAFDAC is not doing its work.”

Alausa said all pharmacies in the country should be regulated and monitored and the licence of the practitioners revoked if found wanting.

“All the healthcare facilities are not regulated,” he said.

Alausa said in the Western world, every healthcare facility has a licence to do business, adding that such licences have different layers.


The ministerial nominee also said the country needs to operate a private sector-driven healthcare economy, adding that it is what the nation needs to fix the health sector.

Click on the link below to join TheCable Channel on WhatsApp for your Breaking News, Business Analysis, Politics, Fact Check, Sports and Entertainment News!



No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment

error: Content is protected from copying.